Takeda Pharmaceuticals U.S.A., Inc. 3
3 · Myovant Sciences Ltd. · Filed Mar 29, 2018
Insider Transaction Report
Form 3
MILLENNIUM PHARMACEUTICALS INC
10% Owner
Holdings
- 7,420,625
Common Stock
Footnotes (2)
- [F1]On March 19, 2018, Takeda Pharmaceuticals International AG ("TPIZ") sold 7,420,625 shares of common stock of Myovant Sciences Ltd. to Millennium Pharmaceuticals, Inc. ("Millennium"). As of the date of this filing: Millennium is owned by Takeda Pharmaceuticals U.S.A., Inc. ("TPUSA"); 41.05% of the outstanding common stock of TPUSA is owned by TPIZ and 58.95% of the outstanding common stock of TPUSA is owned by Takeda Pharmaceuticals Company Limited ("TPC"); 86.831% of the outstanding shares of TPIZ are owned by Takeda Pharma A/S (Denmark) ("TPAS") and 13.1680% of the outstanding shares of TPIZ are owned by Takeda Europe Holdings BV (Netherlands) ("TEHBV"); TPAS is owned by Takeda A/S (Denmark) ("TAS"); 76.09% of the outstanding shares of TAS are owned by TPC and 23.91% of the outstanding shares of TAS are owned by TEHBV.
- [F2](Continued from footnote 1) TEHBV is wholly-owned by TPC. TPIZ, TPC, TPAS, TEHBV and TAS previously reported this transaction on a Form 4 filed March 21, 2018. Each of the Reporting Persons (other than Millennium) disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein.